Citius PharmaceuticalsCTXR 
$0.511.80%24h
1.80%24h
Global rank22386
Market cap$77.16M
Change 7d-11.61%
YTD Performance-32.89%
SP500 benchmarkUnderperform
P/E-2.32
P/S0
Revenue$0
Earnings-$32.54M
Dividend yield-
Main Sector
Healthcare
EPS for Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals has an EPS of $-0.22. In 2022, the company made an earnings per share (EPS) of $-0.23. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for CTXR
-
Value:-
EPS history for Citius Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.22 | -4.35% |
| 2022 | -$0.23 | 0.00% |
| 2021 | -$0.23 | -48.89% |
| 2020 | -$0.45 | - |
View the highest EPS stocks
